Chimera Investment Q1 2026 Revenue Miss Reinforces Bearish Narratives On Earnings Volatility

Chimera Investment (CIM) opened 2026 with Q1 total revenue of US$47.0 million and basic EPS of a US$0.78 loss, setting a cautious tone around the latest financial update. Over the past year, quarterly revenue has moved between US$38.2 million and US$201.0 million, while basic EPS has ranged from a US$2.06 loss to US$1.79, giving you a wide band of outcomes to weigh as you consider how sustainable current margins are.

See our full analysis for Chimera Investment.

With the headline numbers on the table, the next step is to see how these results line up with the widely followed narratives around Chimera Investment's growth potential and risk profile.

See what the community is saying about Chimera Investment

Losses Widen On A 12 Month View

• On a trailing 12 month basis to Q1 2026, Chimera Investment recorded total revenue of US$214.9 million and a net loss of US$66.5 million, compared with quarterly net income figures that have swung between a US$168.3 million loss and a US$145.9 million profit over the last six reported quarters.
• Critics in the bearish camp focus on this unprofitable 12 month picture, arguing that exposure to credit sensitive and legacy non agency mortgage backed securities and the risk of asset write downs could keep earnings volatile, even though quarterly results have already ranged from a US$2.06 loss per share to a US$1.79 profit, which shows how quickly reported EPS can move when markets or credit conditions change.
  • Bears point to losses having widened by about 25.2% per year over the past five years, and see the recent US$0.78 loss per share in Q1 2026 as consistent with that longer term trend.
  • At the same time, the move from a US$6.5 million profit in Q4 2025 to a US$65.0 million loss in Q1 2026 underlines just how sensitive Chimera Investment's results are to shifts in funding costs and portfolio marks, which is exactly the earnings instability bears are worried about.

On this backdrop, skeptics are asking whether recent volatility is a warning sign or just part of the usual mortgage REIT cycle, and they unpack that concern in more detail in the 🐻 Chimera Investment Bear Case.

Premium P/S Multiple Despite Losses

• The stock trades on a P/S of 5.3x, above both the peer average of 2.8x and the US Mortgage REITs industry average of 4.8x, even though the latest trailing 12 month data shows a net loss of US$66.5 million and basic EPS of a US$0.80 loss.
• Consensus narrative watchers will notice an interesting tension here, because analysts looking out three years expect revenue to grow around 7% per year and earnings to reach about US$168.2 million. Yet the market today is already assigning a richer P/S multiple than peers while the current price of US$13.54 still sits below both the DCF fair value of US$14.50 and the analyst consensus target of US$14.83.
  • Supporters of the consensus view may see the roughly 9.5% gap between the share price and the analyst target alongside the modest discount to DCF fair value as room for those growth expectations to play out, even while the company is loss making today.
  • More cautious investors may look at the same premium P/S ratio and ask whether the current unprofitable 12 month record really justifies paying more than the sector, especially when net income has moved between a US$168.3 million loss and a US$145.9 million profit across the last six quarters.

High Dividend And Leverage Press The Bear Case

• The stock currently offers a trailing dividend yield of 10.93%, yet that payout is described as not well covered by earnings or free cash flow and sits alongside debt that is not well covered by operating cash flow, all while the trailing 12 month result shows a net loss of US$66.5 million.
• What stands out when testing the bearish narrative is how these payout and balance sheet pressures sit next to analyst expectations for revenue to grow about 21% per year and earnings to turn positive within three years. This means bears see the generous yield and leverage as key weak spots even if the forecasts eventually prove accurate.
  • Bears argue that a high dividend policy in the face of losses and limited operating cash coverage could force more reliance on external funding, a risk that looks more pointed when quarterly net income has already swung from a US$145.9 million profit in Q1 2025 to a US$65.0 million loss in Q1 2026.
  • Supporters of the bullish growth outlook may point to the projected 98.85% annual earnings growth rate, but the combination of a double digit yield and negative trailing EPS means any setback in that path could put both the dividend and book value under pressure, which is central to the bearish case.

Supporters of the more optimistic view argue there is more to the story than the recent loss, especially around the revenue growth forecasts and acquisition driven fee income, and they set that case out in full in the 🐂 Chimera Investment Bull Case.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Chimera Investment on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Mixed feelings about the latest results and dividend? Use the figures here as a starting point, then move quickly to test your own thesis against the 2 key rewards and 2 important warning signs.

See What Else Is Out There

Chimera Investment is juggling widening losses, a premium P/S multiple, and a high dividend that is not well covered by earnings or operating cash flow.

If that mix of losses, rich valuation and balance sheet pressure makes you uneasy, compare it with companies screened for stronger finances using the solid balance sheet and fundamentals stocks screener (44 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com